Philippines-first medical-device regulatory support

Bring your medical product to market with a controlled regulatory plan.

G9C3 helps manufacturers and distributors classify medical products, close submission gaps, organize technical documents, and support market entry with qualified local partners.

Start with a short fit check. Suitable engagements proceed through a defined, paid classification, readiness-assessment or jurisdiction-roadmap scope.

The C3 operating model

Classification. Compliance. Coordination.

One disciplined framework from first pathway decision to a controlled, submission-ready package.

01

Classification

Determine the likely product category, risk class, pathway, local-role requirements and submission route.

02

Compliance

Review certificates, quality records, safety and performance evidence, labels, IFUs and dossier completeness.

03

Coordination

Assign responsibilities and track actions between manufacturers, distributors, laboratories and qualified partners.

What you receiveEvery engagement produces a documented assessment, controlled action list or submission-preparation record appropriate to the agreed scope.

G9 Β· Nine regulatory markets

One dossier. A wider world.

G9C3 is establishing its principal operating capability in the Philippines. Other jurisdictions are accepted only when the required internal knowledge, qualified local partner and legally appropriate applicant or representative are confirmed.

Philippines
United States
European Union
United Kingdom
Canada
Australia
Singapore
Japan
South Korea

A market shown here is not automatically available for every product or engagement. Scope and partner capability are confirmed before work begins.

Capability map Β· transparent by design

Know the market. Know the operating model.

The Philippines is G9C3's principal market. International work expands through verified capability and qualified local relationships.

PhilippinesPhilippine FDA
Principal market
United StatesU.S. FDA
Partner-supported expansion
European UnionEU MDR / IVDR
Partner-supported expansion
United KingdomMHRA
Partner-supported expansion
CanadaHealth Canada
Partner-supported expansion
AustraliaTGA
Partner-supported expansion
SingaporeHSA
Partner-supported expansion
JapanPMDA / MHLW
Capability development
South KoreaMFDS
Capability development

Philippines-first pathway

A controlled route from product identity to lifecycle.

  1. 01Product & intended use
  2. 02Classification & route
  3. 03Local role & authority
  4. 04Dossier, label & evidence
  5. 05Submission or handover
  6. 06Tracking & lifecycle

Route details are confirmed for the product and engagement. This diagram is a planning framework, not a representation of government procedure.

Regulatory services

Build the evidence path before you file.

Defined services for manufacturers and distributors that need rigorous regulatory support without building a full in-house department. Deliverables are selected and priced according to the agreed scope.

01
Regulatory strategy

Clarify the likely classification, regulatory route, local-role requirements, evidence needs and preliminary market-entry assumptions before committing to a full project.

Possible deliverablesClassification assessment Β· Pathway memorandum Β· Document checklist Β· Responsibility matrix
02
Readiness assessment

Determine whether the available dossier is complete, consistent, current and suitable for the selected submission route.

Possible deliverablesMaster inventory Β· Completeness assessment Β· Certificate tracker Β· Prioritized gap plan
03
Technical dossier organization

Convert scattered files into a controlled regulatory workspace with clear ownership, version history, indexing and submission status.

Possible deliverablesFolder architecture Β· Document register Β· Naming convention Β· Technical index
04
Labelling & IFU review

Compare product names, models, intended use, claims, symbols, warnings and manufacturer details across the label, IFU, certificates and dossier.

Possible deliverablesConsistency matrix Β· Marked review copy Β· Missing-information list Β· Correction tracker
05
Submission coordination

Coordinate document requests, administrative preparation, translations, legalization, qualified local-party activities, handover and response tracking.

Possible deliverablesAction tracker Β· Partner handover record Β· Correspondence log Β· Deficiency-response tracker
06
Lifecycle support

Maintain control after submission through correspondence, variations, renewals, certificate monitoring and regulatory-document updates.

Possible deliverablesRenewal calendar Β· Change log Β· Certificate monitor Β· Outstanding-risk report

Deliverables may include the items shown above depending on scope. Functions legally reserved for an authorized applicant or qualified local party remain with that party.

The controlled submission system

From scattered files to regulatory control.

G9C3 does more than prepare forms. We build a controlled project system around the product, evidence, responsibilities, decisions and deadlines.

01

Assess

Inventory the dossier, verify what exists and expose critical gaps.

02

Organize

Standardize naming, indexing, version history and ownership.

03

Prepare

Build the administrative and technical package for the correct route.

04

Coordinate

Track questions, responses and qualified parties to documented outcome.

Regulatory control center Β· illustrative view

See what is ready. Expose what is missing.

An assessment turns a document pile into a measurable plan with ownership, version history, gap actions and human review.

Sample assessment Β· RA-2607

Submission readiness

71%
18 verified7 in review4 gap actions
Product & pathwayConfirmed
100%
Legal & authorizationIn review
82%
Quality evidenceIn review
76%
Technical dossierGap actions
64%
Label & IFUGap actions
58%
Post-market planNot complete
42%

Illustrative data only. Every client score is evidence-based and engagement-specific.

Controlled workspace

Master document register

Human reviewed
Manufacturer authorizationManufacturerv2.1Verified
ISO 13485 certificateQuality2026Verified
Device descriptionTechnicalv4.0Review
Risk management fileQualityv3.2Review
Label & IFU setManufacturerv1.8Gap
Version historyIssue registerRenewal calendar

Eight controlled stages

A visible path from qualification to closure.

  1. 01

    Qualify

    Confirm product, market, client authority and available evidence.

  2. 02

    Engage

    Define scope, responsibilities, fees and project limitations.

  3. 03

    Activate

    Create the project number, controlled folder and action tracker.

  4. 04

    Assess

    Review classification, pathway, completeness, labels and risks.

  5. 05

    Remediate

    Coordinate corrections, translations and missing evidence.

  6. 06

    Handover

    Prepare the authorized applicant or partner for submission.

  7. 07

    Track

    Control authority questions, deadlines and deficiency responses.

  8. 08

    Close

    Deliver the final archive, risk report and renewal information.

CONTROLLED Β· SAMPLE

Dossier gap register

CriticalOwnerDue
REVIEW Β· SAMPLE

Label & IFU consistency

NamesModelsClaims
PROJECT Β· SAMPLE

Responsibility matrix

G9C3ClientPartner
TRACKER Β· SAMPLE

Submission timeline

ActionsResponsesDecisions

Samples contain no client information. Actual documents, names and outcomes are never published without written permission.

Honest proof Β· disclosure controlled

Show the work before claiming the outcome.

G9C3 case studies follow a documented structure. Client names, confidential records, timelines and results are published only when verified and approved in writing.

01

Dossier control

Initial condition
Technical and quality documents are distributed across email, shared drives and uncontrolled folders.
G9C3 work
Build a master inventory, naming system, version record, gap register and responsibility matrix.
Published outcome
Added only after validation, client approval and removal of confidential information.
02

Product consistency review

Initial condition
Product names, models or intended-use statements differ across certificates, labels, IFUs and technical records.
G9C3 work
Compare the complete document set, record each inconsistency and coordinate controlled corrections.
Published outcome
Added only after validation, client approval and removal of confidential information.
03

Deficiency-response coordination

Initial condition
Authority questions require evidence and decisions from several organizations under a fixed deadline.
G9C3 work
Assign owners, control response versions, record supporting evidence and maintain the correspondence history.
Published outcome
Added only after validation, client approval and removal of confidential information.

Product workstreams

Technical evidence changes with the product.

G9C3 structures the regulatory workstream around intended use, product type, risk, available evidence and the selected market.

01

Medical devices

Classification, quality, safety, performance and technical-document readiness.

02

Dental devices

Dental materials, equipment, labels, IFUs and authorization records.

03

In vitro diagnostics

Intended use, performance evidence, labeling and registration strategy.

04

Software & digital health

Software evidence, risk, cybersecurity and human-reviewed AI workstreams.

Independent Β· Philippines based

Regulatory structure for teams without a full international department.

G9C3 Regulatory Solutions is an independent regulatory consulting and project-management company supporting medical-device, dental-device and IVD manufacturers and distributors.

01

Who we support

  • Foreign manufacturers preparing for Philippine market entry
  • Philippine importers and distributors organizing manufacturer evidence
  • Small and medium manufacturers without a full regulatory department
  • Technical, commercial and country partners needing controlled project support
02

How we operate

Projects are organized through controlled file names, version histories, action trackers, approval records and communication logs. Country-specific functions are assigned only after partner capability is verified.

03

What guides the work

AccuracyTransparencyControlIndependenceConfidentialityHuman accountability

Worldwide regulatory advisory team

The people behind G9C3 Regulatory Solutions.

Five regulatory advisors supporting disciplined technical review, market-entry planning and human accountability across G9C3 engagements worldwide.

Portrait of Kim Trautman PhD

Kim Trautman PhD

Regulatory Advisor

Portrait of Caroline Rhim PhD

Caroline Rhim PhD

Regulatory Advisor

Portrait of Natasha Griffin PhD

Natasha Griffin PhD

Regulatory Advisor

Portrait of Melissa Hall PhD

Melissa Hall PhD

Regulatory Advisor

Portrait of Andrie Udal PhD

Andrie Udal PhD

Regulatory Advisor

Human accountability network

Every judgment has an owner.

Roles are assigned by scope. Named personnel, technical consultants and country-partner credentials are confirmed in the engagement record.

01

Founder & managing director

Strategy, regulatory oversight, client relationships and final review.

02

Regulatory project manager

Timelines, communication, issue control and submission tracking.

03

Documentation specialist

Inventory, gap support, dossier organization and version control.

04

Quality reviewer

Independent review, internal audit, corrective actions and data checks.

05

Qualified partners

Jurisdiction-specific and technical functions confirmed per engagement.

Technology-enabled Β· Human-accountable

AI accelerates the work. People own the judgment.

AI may help build document inventories, compare product information, prepare trackers, identify possible inconsistencies, summarize records and perform internal formatting checks. Every regulatory conclusion and client-facing output remains subject to qualified human review.

Permitted support

  • Inventories, indexes and controlled trackers
  • Document comparisons and possible inconsistency flags
  • Administrative summaries and internal formatting checks

Never used to

  • Invent requirements, data, certificates or evidence
  • Make an unreviewed final classification or authority decision
  • Replace an authorized signatory or submit unverified information
ControlledAudit trails & versions
Evidence-basedNo fabricated claims
IndependentNo government affiliation
New York officeG9C3 Regulatory Solutions, Inc.

41 Madison Avenue
Midtown Manhattan, 31st Floor
New York City, NY 10010, USA

inquire@g9c3.com

Your first move

Know what is missing before it costs you time.

Tell us about your product, manufacturer, intended use, target market, available certificates, current dossier and desired timeline. G9C3 will determine whether the appropriate next step is a classification assessment, readiness review, jurisdiction roadmap or defined coordination project.

The form will identify any required information before sending.

Submissions are processed by FormSubmit and delivered by email to G9C3. Initial contact confirms fit and scope; detailed regulatory analysis is normally performed as a paid professional service.